Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...

In a landmark decision that challenges the European Commission’s transparency standards, the General Court of the European ...

A ruling by the EU’s top court over undisclosed vaccine deal messages casts a shadow over Ursula von der Leyen’s presidency ...

The EU Court ruled against the Commission for failing to justify its refusal to release texts between von der Leyen and ...

A top European court says the European Commission failed to provide a credible explanation for refusing The New York Times ...

BMO Capital cut Terns Pharmaceuticals' price target from $26 to $15, citing costlier capital conditions despite maintaining ...

A top court Wednesday ruled the European Commission failed the transparency test by declining to release text messages sent ...